U.S., Sept. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07796152) titled 'Suzetrigine vs. Standard Care Pain Relief Following Outpatient Knee Replacement Surgery' on Aug. 27.
Brief Summary: The purpose of this research is to see if a person having an outpatient total knee replacement will have a difference in their pain and the amount of pain medication (opioids) used after discharge if they are given suzetrigine (a non-opioid pain medicine, also known as Journavx(R)) in addition to the standard pain medicines usually prescribed. Participants will complete a daily pain and medication diary and survey for up to 14 days post-operatively and on day 30.
Study Start Date: Sept., 2026
Study Type: INTERVENTION...